Global Alzheimer’s Disease Therapeutics and Diagnostics Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Alzheimer’s Disease Therapeutics and Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Lumbar puncture test
  • 1.4.3 Computed tomography (CT) scan
  • 1.4.4 Magnetic resonance imaging (MRI)
  • 1.4.5 Electroencephalography (EEG)
  • 1.4.6 Positron emission tomography (PET) scan
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Marketed Drugs
  • 1.5.3 Pipeline Drugs
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Perspective (2015-2026)
• 2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Growth Trends by Regions
  • 2.2.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Alzheimer’s Disease Therapeutics and Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Alzheimer’s Disease Therapeutics and Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Market Size
  • 3.1.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio
  • 3.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2019
• 3.3 Alzheimer’s Disease Therapeutics and Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
• 3.5 Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 6.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 7.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 8.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in China (2019-2020)
• 8.3 China Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 8.4 China Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 9.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 10.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 11.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in India (2019-2020)
• 11.3 India Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 11.4 India Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2015-2020)
• 12.2 Alzheimer’s Disease Therapeutics and Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview
  • 13.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.1.4 Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 Eisai
  • 13.2.1 Eisai Company Details
  • 13.2.2 Eisai Business Overview
  • 13.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.2.4 Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.2.5 Eisai Recent Development
• 13.3 Novartis
  • 13.3.1 Novartis Company Details
  • 13.3.2 Novartis Business Overview
  • 13.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.3.4 Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.3.5 Novartis Recent Development
• 13.4 Forest Laboratories
  • 13.4.1 Forest Laboratories Company Details
  • 13.4.2 Forest Laboratories Business Overview
  • 13.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.4.4 Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.4.5 Forest Laboratories Recent Development
• 13.5 TauRx Therapeutics
  • 13.5.1 TauRx Therapeutics Company Details
  • 13.5.2 TauRx Therapeutics Business Overview
  • 13.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.5.4 TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.5.5 TauRx Therapeutics Recent Development
• 13.6 AC Immune
  • 13.6.1 AC Immune Company Details
  • 13.6.2 AC Immune Business Overview
  • 13.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.6.4 AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.6.5 AC Immune Recent Development
• 13.7 Johnson & Johnson.
  • 13.7.1 Johnson & Johnson. Company Details
  • 13.7.2 Johnson & Johnson. Business Overview
  • 13.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.7.4 Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.7.5 Johnson & Johnson. Recent Development
• 13.8 H. Lundbeck
  • 13.8.1 H. Lundbeck Company Details
  • 13.8.2 H. Lundbeck Business Overview
  • 13.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Introduction
  • 13.8.4 H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2015-2020)
  • 13.8.5 H. Lundbeck Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer